Oncology News

Researchers have caught a protein they previously implicated in a variety of cancer-promoting roles performing a vital function in cell division, survival and development of brain tumors.

A new cancer drug developed and tested in Sutton is set to prolong the lives of London's adult leukaemia sufferers.

Women with interruptions in health insurance coverage or with low income levels had a significantly increased likelihood of failing to receive breast cancer care that is in concordance with recommended treatment guidelines, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic ... (more)

Meghan O'Brien, 31, of Huntley, left, takes a walk in the woods with her dad, Ken O'Brien, and their dog, "Max", at Raceway Woods Forest Preserve in Carpentersville, Ill., Nov. 19, 2013.

Among African-American women with breast cancer, increased levels of the protein HSET were associated with worse breast cancer outcomes, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Dec. 6-9.

Human Performance Labs traditionally have been the province of elite athletes who use the assessment as a training tool to give them that critical competitive edge.

Liz D'Amato has a story that is all too common. In November of last year, the mother of three from Dayton received a phone call that confirmed a diagnosis thousands of women receive each year: cancer.

"Your body cannot heal without play. Your mind cannot heal without laughter. Your soul cannot heal without joy."

Sydney, 4, and Easton Ulseth, 2, take a turn on Santa's lap Friday night during the Celebration of Lights at Northside Hospital-Forsyth.

As Ryan Eaton lay in hospital beds, receiving treatment for synovial sarcoma that would eventually metastasize and spread throughout his body, he worried about other people.

Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited , today announced results from a retrospective, subgroup analysis of the Phase 3 VISTA study that showed a higher cumulative dose of VELCADE suggests improved overall survival in previously untreated patients with multiple myeloma .

In this October 2012 photo provided by The Children's Hospital of Philadelphia, Emily Whitehead is checked by pediatric oncologist, Dr. Stephan A. Grupp, at the hospital.

Due to promising preliminary results, officials at the National Cancer Institute decided to release them early on December 5 before a full analysis of the trial was completed Due to promising preliminary results, officials at the National Cancer Institute decided to release them early on December 5 before a full analysis of the trial was completed ... (more)

ZIOPHARM Oncology, Inc. today announced the unanimous approval of the National Institutes of Health's Recombinant DNA Advisory Committee for the initiation of a Phase 1 study of Ad-RTS-IL-12, an adenoviral vector engineered to express interleukin-12 under the control of veledimex, an oral activator, in subjects with recurrent or progressive ... (more)

Fowler High student Gabriel Rodriguez holds a present and Christmas poster he drew, as he and other members of the school's Redcat Men's Alliance wait to give the presents to young patients at Children's Hospital Central California, Friday afternoon, December 6, 2013.

One of hardest parts of a doctor's job - delivering bad news to patients and their loved ones - is rarely addressed in medical school.

The most-recognized oncology and hematology brand in North America is Epogen . The brand was most recognized by 4.9 percent of physicians in a survey conducted by Brand Institute Inc. during second-quarter 2013.

The drug candidate used in the research has been developed by scientists from Karolinska Institutet and a Swedish company following its initial identification at the same university.

Today Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability biomarkers for several cancers, in particular colorectal cancer .

The members of William House, who chose the Teenage Cancer Trust to be their charity following the death of fellow pupil Georgie Brock in 2009, raised the cash in just three years.